Gan & Lee Pharmaceuticals. (603087.SS)
CNY 45.54
(0.35%)
CNY 45.54
(0.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.85 Billion CNY | 36.85% |
| 2022 | 1.3 Billion CNY | -59.38% |
| 2021 | 3.21 Billion CNY | 5.26% |
| 2020 | 3.05 Billion CNY | 14.98% |
| 2019 | 2.65 Billion CNY | 20.8% |
| 2018 | 2.19 Billion CNY | 1.57% |
| 2017 | 2.16 Billion CNY | 34.91% |
| 2016 | 1.6 Billion CNY | 44.57% |
| 2015 | 1.11 Billion CNY | 31.53% |
| 2014 | 844.15 Million CNY | 35.01% |
| 2013 | 625.23 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 523.09 Million CNY | 30.18% |
| 2024 Q1 | 401.81 Million CNY | -11.74% |
| 2024 Q3 | 725.97 Million CNY | 38.78% |
| 2023 Q3 | 517.37 Million CNY | 3.49% |
| 2023 Q1 | 407.16 Million CNY | 19.64% |
| 2023 Q2 | 499.94 Million CNY | 22.78% |
| 2023 Q4 | 455.24 Million CNY | -12.01% |
| 2023 FY | 1.78 Billion CNY | 36.85% |
| 2022 Q1 | 629.63 Million CNY | -36.9% |
| 2022 FY | 1.3 Billion CNY | -59.38% |
| 2022 Q2 | 52.17 Million CNY | -91.71% |
| 2022 Q4 | 340.33 Million CNY | 19.7% |
| 2022 Q3 | 284.31 Million CNY | 444.92% |
| 2021 FY | 3.21 Billion CNY | 5.26% |
| 2021 Q4 | 997.77 Million CNY | 9.09% |
| 2021 Q3 | 914.64 Million CNY | 12.96% |
| 2021 Q2 | 809.7 Million CNY | 63.97% |
| 2021 Q1 | 493.8 Million CNY | -53.16% |
| 2020 Q1 | 429.1 Million CNY | -54.74% |
| 2020 FY | 3.05 Billion CNY | 14.98% |
| 2020 Q4 | 1.05 Billion CNY | 16.5% |
| 2020 Q3 | 904.85 Million CNY | 35.64% |
| 2020 Q2 | 667.08 Million CNY | 55.46% |
| 2019 Q1 | 394.7 Million CNY | 0.0% |
| 2019 FY | 2.65 Billion CNY | 20.8% |
| 2019 Q4 | 948.08 Million CNY | 14.81% |
| 2019 Q3 | 825.77 Million CNY | 69.04% |
| 2019 Q2 | 488.51 Million CNY | 23.77% |
| 2018 FY | 2.19 Billion CNY | 1.57% |
| 2017 Q2 | 451.27 Million CNY | 0.0% |
| 2017 FY | 2.16 Billion CNY | 34.91% |
| 2017 Q1 | 451.27 Million CNY | 0.0% |
| 2016 FY | 1.6 Billion CNY | 44.57% |
| 2015 FY | 1.11 Billion CNY | 31.53% |
| 2014 FY | 844.15 Million CNY | 35.01% |
| 2013 FY | 625.23 Million CNY | 0.0% |